Evaluation of the efficiency and safety of combined treatment with impaza and nitrates in CHD patients with erectile dysfunction

Bulletin of Experimental Biology and Medicine

Volumn 148, Issue 2, 2009, Pages 325-327

  Zhavbert, E S ^a   Kachanova, M V ^a   Tarasov, S A ^a   Dugina, Yu L ^a   Sergeeva, S A ^a   Dovgalevskii, P Ya ^a   Epshtein, O I ^a  

^a Federal Agency for Health Care and Social Development   (Russian Federation)

Author keywords

Coronary heart disease; Erectile dysfunction; Nitrates; Ultralow doses of antibodies to endothelial NO synthase

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE ANTIBODY; IMPAZA; NITRATE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MALE; OPEN STUDY; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIBODIES; CORONARY DISEASE; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; NITRATES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 74949134495     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-009-0688-7     Document Type: Article

References (6)

1. E. B. Mazo, S. I. Gamidov, R. I. Ovchinnikov, and V. V. Iremashvili, Farmateka, No. 4-5, 40-45 (2005).
2. A. V. Martyushev-Poklad and O. I. Epshtein, Poliklinika No. 1, p. 8-9 (2003).
3. E. G. Mutalova, Sh. Z. Sattarov, A. E. Nigmatulina, and B. N. Golubkova, Lechashchii Vrach, No 7, 86-88 (2006).
4. H. Brunner, Cockcroft J.R., Deanfield J. et al. J. Hypertens., 23, No. 2, 233-246 (2005).
5. R. Maas, E. Schwedhelm, J. Albsmeier, and R. H. Boger, Vasc. Med., 7, No. 3, 213-225 (2002).
6. R. A. Stein, Rev. Urol. Vol. 5. 21-27 (2003).